nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefuroxime—Cefazolin—PON1—prostate cancer	0.00353	0.486	CrCbGaD
Cefuroxime—Cefdinir—MPO—prostate cancer	0.00144	0.199	CrCbGaD
Cefuroxime—Cefaclor—MPO—prostate cancer	0.00143	0.197	CrCbGaD
Cefuroxime—Cefradine—CYP3A4—prostate cancer	0.000525	0.0723	CrCbGaD
Cefuroxime—Muscle spasms—Capecitabine—prostate cancer	0.00038	0.000383	CcSEcCtD
Cefuroxime—Pancytopenia—Epirubicin—prostate cancer	0.000375	0.000378	CcSEcCtD
Cefuroxime—Dysuria—Epirubicin—prostate cancer	0.00037	0.000372	CcSEcCtD
Cefuroxime—Neutropenia—Epirubicin—prostate cancer	0.00037	0.000372	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Epirubicin—prostate cancer	0.000367	0.00037	CcSEcCtD
Cefuroxime—Angiopathy—Prednisone—prostate cancer	0.000367	0.00037	CcSEcCtD
Cefuroxime—Pruritus—Estradiol—prostate cancer	0.000366	0.000369	CcSEcCtD
Cefuroxime—Leukopenia—Docetaxel—prostate cancer	0.000365	0.000368	CcSEcCtD
Cefuroxime—Immune system disorder—Prednisone—prostate cancer	0.000365	0.000368	CcSEcCtD
Cefuroxime—Eosinophilia—Doxorubicin—prostate cancer	0.000362	0.000365	CcSEcCtD
Cefuroxime—Palpitations—Docetaxel—prostate cancer	0.000361	0.000363	CcSEcCtD
Cefuroxime—Dyspnoea—Etoposide—prostate cancer	0.000357	0.00036	CcSEcCtD
Cefuroxime—Somnolence—Etoposide—prostate cancer	0.000356	0.000359	CcSEcCtD
Cefuroxime—Cough—Docetaxel—prostate cancer	0.000356	0.000359	CcSEcCtD
Cefuroxime—Hypersensitivity—Mitoxantrone—prostate cancer	0.000355	0.000358	CcSEcCtD
Cefuroxime—Diarrhoea—Estradiol—prostate cancer	0.000354	0.000357	CcSEcCtD
Cefuroxime—Leukopenia—Capecitabine—prostate cancer	0.000354	0.000356	CcSEcCtD
Cefuroxime—Convulsion—Docetaxel—prostate cancer	0.000354	0.000356	CcSEcCtD
Cefuroxime—Drowsiness—Epirubicin—prostate cancer	0.000352	0.000355	CcSEcCtD
Cefuroxime—Infestation—Epirubicin—prostate cancer	0.000352	0.000355	CcSEcCtD
Cefuroxime—Infestation NOS—Epirubicin—prostate cancer	0.000352	0.000355	CcSEcCtD
Cefuroxime—Erythema—Prednisone—prostate cancer	0.000352	0.000355	CcSEcCtD
Cefuroxime—Bronchitis—Doxorubicin—prostate cancer	0.000352	0.000354	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000349	0.000352	CcSEcCtD
Cefuroxime—Palpitations—Capecitabine—prostate cancer	0.000349	0.000352	CcSEcCtD
Cefuroxime—Decreased appetite—Etoposide—prostate cancer	0.000349	0.000351	CcSEcCtD
Cefuroxime—Chest pain—Docetaxel—prostate cancer	0.000348	0.00035	CcSEcCtD
Cefuroxime—Arthralgia—Docetaxel—prostate cancer	0.000348	0.00035	CcSEcCtD
Cefuroxime—Pancytopenia—Doxorubicin—prostate cancer	0.000347	0.00035	CcSEcCtD
Cefuroxime—Renal failure—Epirubicin—prostate cancer	0.000346	0.000349	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Etoposide—prostate cancer	0.000346	0.000349	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	0.000345	0.000348	CcSEcCtD
Cefuroxime—Cough—Capecitabine—prostate cancer	0.000345	0.000347	CcSEcCtD
Cefuroxime—Jaundice—Epirubicin—prostate cancer	0.000344	0.000346	CcSEcCtD
Cefuroxime—Stomatitis—Epirubicin—prostate cancer	0.000344	0.000346	CcSEcCtD
Cefuroxime—Pain—Etoposide—prostate cancer	0.000343	0.000345	CcSEcCtD
Cefuroxime—Urinary tract infection—Epirubicin—prostate cancer	0.000343	0.000345	CcSEcCtD
Cefuroxime—Dizziness—Estradiol—prostate cancer	0.000342	0.000345	CcSEcCtD
Cefuroxime—Dysuria—Doxorubicin—prostate cancer	0.000342	0.000344	CcSEcCtD
Cefuroxime—Neutropenia—Doxorubicin—prostate cancer	0.000342	0.000344	CcSEcCtD
Cefuroxime—Upper respiratory tract infection—Doxorubicin—prostate cancer	0.00034	0.000342	CcSEcCtD
Cefuroxime—Cephalexin—CYP3A4—prostate cancer	0.00034	0.0468	CrCbGaD
Cefuroxime—Sweating—Epirubicin—prostate cancer	0.000338	0.00034	CcSEcCtD
Cefuroxime—Arthralgia—Capecitabine—prostate cancer	0.000337	0.000339	CcSEcCtD
Cefuroxime—Chest pain—Capecitabine—prostate cancer	0.000337	0.000339	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	0.000334	0.000337	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Epirubicin—prostate cancer	0.000333	0.000336	CcSEcCtD
Cefuroxime—Anaphylactic shock—Docetaxel—prostate cancer	0.000333	0.000336	CcSEcCtD
Cefuroxime—Sinusitis—Epirubicin—prostate cancer	0.000331	0.000333	CcSEcCtD
Cefuroxime—Diarrhoea—Mitoxantrone—prostate cancer	0.00033	0.000332	CcSEcCtD
Cefuroxime—Vomiting—Estradiol—prostate cancer	0.000329	0.000331	CcSEcCtD
Cefuroxime—Agranulocytosis—Epirubicin—prostate cancer	0.000329	0.000331	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Etoposide—prostate cancer	0.000328	0.00033	CcSEcCtD
Cefuroxime—Thrombocytopenia—Docetaxel—prostate cancer	0.000326	0.000329	CcSEcCtD
Cefuroxime—Rash—Estradiol—prostate cancer	0.000326	0.000329	CcSEcCtD
Cefuroxime—Drowsiness—Doxorubicin—prostate cancer	0.000326	0.000328	CcSEcCtD
Cefuroxime—Infestation NOS—Doxorubicin—prostate cancer	0.000326	0.000328	CcSEcCtD
Cefuroxime—Infestation—Doxorubicin—prostate cancer	0.000326	0.000328	CcSEcCtD
Cefuroxime—Dermatitis—Estradiol—prostate cancer	0.000326	0.000328	CcSEcCtD
Cefuroxime—Tachycardia—Docetaxel—prostate cancer	0.000325	0.000328	CcSEcCtD
Cefuroxime—Headache—Estradiol—prostate cancer	0.000324	0.000326	CcSEcCtD
Cefuroxime—Skin disorder—Docetaxel—prostate cancer	0.000324	0.000326	CcSEcCtD
Cefuroxime—Agitation—Prednisone—prostate cancer	0.000324	0.000326	CcSEcCtD
Cefuroxime—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.000323	0.000326	CcSEcCtD
Cefuroxime—Angioedema—Prednisone—prostate cancer	0.000322	0.000324	CcSEcCtD
Cefuroxime—Renal failure—Doxorubicin—prostate cancer	0.000321	0.000323	CcSEcCtD
Cefuroxime—Urticaria—Etoposide—prostate cancer	0.000319	0.000321	CcSEcCtD
Cefuroxime—Haemoglobin—Epirubicin—prostate cancer	0.000318	0.00032	CcSEcCtD
Cefuroxime—Stomatitis—Doxorubicin—prostate cancer	0.000318	0.00032	CcSEcCtD
Cefuroxime—Jaundice—Doxorubicin—prostate cancer	0.000318	0.00032	CcSEcCtD
Cefuroxime—Anorexia—Docetaxel—prostate cancer	0.000318	0.00032	CcSEcCtD
Cefuroxime—Body temperature increased—Etoposide—prostate cancer	0.000317	0.000319	CcSEcCtD
Cefuroxime—Abdominal pain—Etoposide—prostate cancer	0.000317	0.000319	CcSEcCtD
Cefuroxime—Urinary tract infection—Doxorubicin—prostate cancer	0.000317	0.000319	CcSEcCtD
Cefuroxime—Haemorrhage—Epirubicin—prostate cancer	0.000316	0.000319	CcSEcCtD
Cefuroxime—Hepatitis—Epirubicin—prostate cancer	0.000316	0.000319	CcSEcCtD
Cefuroxime—Thrombocytopenia—Capecitabine—prostate cancer	0.000316	0.000318	CcSEcCtD
Cefuroxime—Tachycardia—Capecitabine—prostate cancer	0.000315	0.000317	CcSEcCtD
Cefuroxime—Skin disorder—Capecitabine—prostate cancer	0.000313	0.000316	CcSEcCtD
Cefuroxime—Sweating—Doxorubicin—prostate cancer	0.000313	0.000315	CcSEcCtD
Cefuroxime—Urinary tract disorder—Epirubicin—prostate cancer	0.000312	0.000315	CcSEcCtD
Cefuroxime—Hyperhidrosis—Capecitabine—prostate cancer	0.000312	0.000314	CcSEcCtD
Cefuroxime—Urethral disorder—Epirubicin—prostate cancer	0.00031	0.000312	CcSEcCtD
Cefuroxime—Hepatobiliary disease—Doxorubicin—prostate cancer	0.000308	0.000311	CcSEcCtD
Cefuroxime—Anorexia—Capecitabine—prostate cancer	0.000308	0.00031	CcSEcCtD
Cefuroxime—Nausea—Estradiol—prostate cancer	0.000307	0.00031	CcSEcCtD
Cefuroxime—Vomiting—Mitoxantrone—prostate cancer	0.000306	0.000309	CcSEcCtD
Cefuroxime—Sinusitis—Doxorubicin—prostate cancer	0.000306	0.000308	CcSEcCtD
Cefuroxime—Convulsion—Prednisone—prostate cancer	0.000305	0.000307	CcSEcCtD
Cefuroxime—Agranulocytosis—Doxorubicin—prostate cancer	0.000304	0.000307	CcSEcCtD
Cefuroxime—Rash—Mitoxantrone—prostate cancer	0.000304	0.000306	CcSEcCtD
Cefuroxime—Dermatitis—Mitoxantrone—prostate cancer	0.000304	0.000306	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000304	0.000306	CcSEcCtD
Cefuroxime—Headache—Mitoxantrone—prostate cancer	0.000302	0.000304	CcSEcCtD
Cefuroxime—Arthralgia—Prednisone—prostate cancer	0.0003	0.000302	CcSEcCtD
Cefuroxime—Erythema multiforme—Epirubicin—prostate cancer	0.000299	0.000301	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	0.000298	0.0003	CcSEcCtD
Cefuroxime—Dyspnoea—Docetaxel—prostate cancer	0.000297	0.000299	CcSEcCtD
Cefuroxime—Somnolence—Docetaxel—prostate cancer	0.000296	0.000298	CcSEcCtD
Cefuroxime—Hypersensitivity—Etoposide—prostate cancer	0.000295	0.000298	CcSEcCtD
Cefuroxime—Haemoglobin—Doxorubicin—prostate cancer	0.000294	0.000296	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.000294	0.000296	CcSEcCtD
Cefuroxime—Dyspepsia—Docetaxel—prostate cancer	0.000293	0.000295	CcSEcCtD
Cefuroxime—Hepatitis—Doxorubicin—prostate cancer	0.000293	0.000295	CcSEcCtD
Cefuroxime—Haemorrhage—Doxorubicin—prostate cancer	0.000293	0.000295	CcSEcCtD
Cefuroxime—Decreased appetite—Docetaxel—prostate cancer	0.00029	0.000292	CcSEcCtD
Cefuroxime—Urinary tract disorder—Doxorubicin—prostate cancer	0.000289	0.000291	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000288	0.00029	CcSEcCtD
Cefuroxime—Dyspnoea—Capecitabine—prostate cancer	0.000288	0.00029	CcSEcCtD
Cefuroxime—Anaphylactic shock—Prednisone—prostate cancer	0.000287	0.000289	CcSEcCtD
Cefuroxime—Angiopathy—Epirubicin—prostate cancer	0.000287	0.000289	CcSEcCtD
Cefuroxime—Urethral disorder—Doxorubicin—prostate cancer	0.000287	0.000289	CcSEcCtD
Cefuroxime—Nausea—Mitoxantrone—prostate cancer	0.000286	0.000288	CcSEcCtD
Cefuroxime—Immune system disorder—Epirubicin—prostate cancer	0.000286	0.000288	CcSEcCtD
Cefuroxime—Pain—Docetaxel—prostate cancer	0.000285	0.000287	CcSEcCtD
Cefuroxime—Dyspepsia—Capecitabine—prostate cancer	0.000284	0.000286	CcSEcCtD
Cefuroxime—Chills—Epirubicin—prostate cancer	0.000284	0.000286	CcSEcCtD
Cefuroxime—Pruritus—Etoposide—prostate cancer	0.000284	0.000286	CcSEcCtD
Cefuroxime—Tachycardia—Prednisone—prostate cancer	0.00028	0.000283	CcSEcCtD
Cefuroxime—Decreased appetite—Capecitabine—prostate cancer	0.00028	0.000283	CcSEcCtD
Cefuroxime—Skin disorder—Prednisone—prostate cancer	0.000279	0.000281	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000279	0.000281	CcSEcCtD
Cefuroxime—Hyperhidrosis—Prednisone—prostate cancer	0.000278	0.00028	CcSEcCtD
Cefuroxime—Erythema multiforme—Doxorubicin—prostate cancer	0.000277	0.000279	CcSEcCtD
Cefuroxime—Pain—Capecitabine—prostate cancer	0.000276	0.000278	CcSEcCtD
Cefuroxime—Erythema—Epirubicin—prostate cancer	0.000275	0.000277	CcSEcCtD
Cefuroxime—Diarrhoea—Etoposide—prostate cancer	0.000274	0.000276	CcSEcCtD
Cefuroxime—Anorexia—Prednisone—prostate cancer	0.000274	0.000276	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Docetaxel—prostate cancer	0.000272	0.000274	CcSEcCtD
Cefuroxime—Flatulence—Epirubicin—prostate cancer	0.000271	0.000273	CcSEcCtD
Cefuroxime—Angiopathy—Doxorubicin—prostate cancer	0.000266	0.000268	CcSEcCtD
Cefuroxime—Dizziness—Etoposide—prostate cancer	0.000265	0.000267	CcSEcCtD
Cefuroxime—Muscle spasms—Epirubicin—prostate cancer	0.000265	0.000267	CcSEcCtD
Cefuroxime—Immune system disorder—Doxorubicin—prostate cancer	0.000264	0.000266	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Capecitabine—prostate cancer	0.000264	0.000266	CcSEcCtD
Cefuroxime—Body temperature increased—Docetaxel—prostate cancer	0.000263	0.000265	CcSEcCtD
Cefuroxime—Abdominal pain—Docetaxel—prostate cancer	0.000263	0.000265	CcSEcCtD
Cefuroxime—Chills—Doxorubicin—prostate cancer	0.000263	0.000265	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000262	0.000264	CcSEcCtD
Cefuroxime—Urticaria—Capecitabine—prostate cancer	0.000256	0.000258	CcSEcCtD
Cefuroxime—Body temperature increased—Capecitabine—prostate cancer	0.000255	0.000257	CcSEcCtD
Cefuroxime—Abdominal pain—Capecitabine—prostate cancer	0.000255	0.000257	CcSEcCtD
Cefuroxime—Vomiting—Etoposide—prostate cancer	0.000255	0.000257	CcSEcCtD
Cefuroxime—Erythema—Doxorubicin—prostate cancer	0.000255	0.000257	CcSEcCtD
Cefuroxime—Agitation—Epirubicin—prostate cancer	0.000253	0.000255	CcSEcCtD
Cefuroxime—Dyspepsia—Prednisone—prostate cancer	0.000253	0.000255	CcSEcCtD
Cefuroxime—Rash—Etoposide—prostate cancer	0.000253	0.000255	CcSEcCtD
Cefuroxime—Dermatitis—Etoposide—prostate cancer	0.000253	0.000254	CcSEcCtD
Cefuroxime—Headache—Etoposide—prostate cancer	0.000251	0.000253	CcSEcCtD
Cefuroxime—Flatulence—Doxorubicin—prostate cancer	0.000251	0.000253	CcSEcCtD
Cefuroxime—Decreased appetite—Prednisone—prostate cancer	0.00025	0.000252	CcSEcCtD
Cefuroxime—Leukopenia—Epirubicin—prostate cancer	0.000247	0.000248	CcSEcCtD
Cefuroxime—Hypersensitivity—Docetaxel—prostate cancer	0.000246	0.000247	CcSEcCtD
Cefuroxime—Muscle spasms—Doxorubicin—prostate cancer	0.000245	0.000247	CcSEcCtD
Cefuroxime—Palpitations—Epirubicin—prostate cancer	0.000243	0.000245	CcSEcCtD
Cefuroxime—Cough—Epirubicin—prostate cancer	0.00024	0.000242	CcSEcCtD
Cefuroxime—Convulsion—Epirubicin—prostate cancer	0.000239	0.00024	CcSEcCtD
Cefuroxime—Nausea—Etoposide—prostate cancer	0.000238	0.00024	CcSEcCtD
Cefuroxime—Hypersensitivity—Capecitabine—prostate cancer	0.000238	0.000239	CcSEcCtD
Cefuroxime—Pruritus—Docetaxel—prostate cancer	0.000236	0.000237	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Prednisone—prostate cancer	0.000235	0.000237	CcSEcCtD
Cefuroxime—Chest pain—Epirubicin—prostate cancer	0.000234	0.000236	CcSEcCtD
Cefuroxime—Arthralgia—Epirubicin—prostate cancer	0.000234	0.000236	CcSEcCtD
Cefuroxime—Agitation—Doxorubicin—prostate cancer	0.000234	0.000236	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	0.000233	0.000235	CcSEcCtD
Cefuroxime—Urticaria—Prednisone—prostate cancer	0.000228	0.00023	CcSEcCtD
Cefuroxime—Pruritus—Capecitabine—prostate cancer	0.000228	0.00023	CcSEcCtD
Cefuroxime—Leukopenia—Doxorubicin—prostate cancer	0.000228	0.00023	CcSEcCtD
Cefuroxime—Diarrhoea—Docetaxel—prostate cancer	0.000228	0.00023	CcSEcCtD
Cefuroxime—Abdominal pain—Prednisone—prostate cancer	0.000227	0.000229	CcSEcCtD
Cefuroxime—Body temperature increased—Prednisone—prostate cancer	0.000227	0.000229	CcSEcCtD
Cefuroxime—Palpitations—Doxorubicin—prostate cancer	0.000225	0.000227	CcSEcCtD
Cefuroxime—Anaphylactic shock—Epirubicin—prostate cancer	0.000225	0.000226	CcSEcCtD
Cefuroxime—Cough—Doxorubicin—prostate cancer	0.000222	0.000224	CcSEcCtD
Cefuroxime—Convulsion—Doxorubicin—prostate cancer	0.000221	0.000222	CcSEcCtD
Cefuroxime—Diarrhoea—Capecitabine—prostate cancer	0.000221	0.000222	CcSEcCtD
Cefuroxime—Dizziness—Docetaxel—prostate cancer	0.00022	0.000222	CcSEcCtD
Cefuroxime—Thrombocytopenia—Epirubicin—prostate cancer	0.00022	0.000222	CcSEcCtD
Cefuroxime—Tachycardia—Epirubicin—prostate cancer	0.000219	0.000221	CcSEcCtD
Cefuroxime—Skin disorder—Epirubicin—prostate cancer	0.000218	0.00022	CcSEcCtD
Cefuroxime—Hyperhidrosis—Epirubicin—prostate cancer	0.000217	0.000219	CcSEcCtD
Cefuroxime—Chest pain—Doxorubicin—prostate cancer	0.000217	0.000219	CcSEcCtD
Cefuroxime—Arthralgia—Doxorubicin—prostate cancer	0.000217	0.000219	CcSEcCtD
Cefuroxime—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	0.000215	0.000217	CcSEcCtD
Cefuroxime—Anorexia—Epirubicin—prostate cancer	0.000214	0.000216	CcSEcCtD
Cefuroxime—Dizziness—Capecitabine—prostate cancer	0.000213	0.000215	CcSEcCtD
Cefuroxime—Vomiting—Docetaxel—prostate cancer	0.000212	0.000213	CcSEcCtD
Cefuroxime—Hypersensitivity—Prednisone—prostate cancer	0.000212	0.000213	CcSEcCtD
Cefuroxime—Rash—Docetaxel—prostate cancer	0.00021	0.000212	CcSEcCtD
Cefuroxime—Dermatitis—Docetaxel—prostate cancer	0.00021	0.000211	CcSEcCtD
Cefuroxime—Headache—Docetaxel—prostate cancer	0.000209	0.00021	CcSEcCtD
Cefuroxime—Anaphylactic shock—Doxorubicin—prostate cancer	0.000208	0.000209	CcSEcCtD
Cefuroxime—Vomiting—Capecitabine—prostate cancer	0.000205	0.000207	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Epirubicin—prostate cancer	0.000205	0.000206	CcSEcCtD
Cefuroxime—Thrombocytopenia—Doxorubicin—prostate cancer	0.000204	0.000205	CcSEcCtD
Cefuroxime—Rash—Capecitabine—prostate cancer	0.000203	0.000205	CcSEcCtD
Cefuroxime—Pruritus—Prednisone—prostate cancer	0.000203	0.000205	CcSEcCtD
Cefuroxime—Dermatitis—Capecitabine—prostate cancer	0.000203	0.000205	CcSEcCtD
Cefuroxime—Tachycardia—Doxorubicin—prostate cancer	0.000203	0.000204	CcSEcCtD
Cefuroxime—Headache—Capecitabine—prostate cancer	0.000202	0.000204	CcSEcCtD
Cefuroxime—Skin disorder—Doxorubicin—prostate cancer	0.000202	0.000203	CcSEcCtD
Cefuroxime—Hyperhidrosis—Doxorubicin—prostate cancer	0.000201	0.000203	CcSEcCtD
Cefuroxime—Dyspnoea—Epirubicin—prostate cancer	0.0002	0.000202	CcSEcCtD
Cefuroxime—Somnolence—Epirubicin—prostate cancer	0.0002	0.000201	CcSEcCtD
Cefuroxime—Anorexia—Doxorubicin—prostate cancer	0.000198	0.0002	CcSEcCtD
Cefuroxime—Nausea—Docetaxel—prostate cancer	0.000198	0.000199	CcSEcCtD
Cefuroxime—Dyspepsia—Epirubicin—prostate cancer	0.000198	0.000199	CcSEcCtD
Cefuroxime—Diarrhoea—Prednisone—prostate cancer	0.000197	0.000198	CcSEcCtD
Cefuroxime—Decreased appetite—Epirubicin—prostate cancer	0.000195	0.000197	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Epirubicin—prostate cancer	0.000194	0.000195	CcSEcCtD
Cefuroxime—Pain—Epirubicin—prostate cancer	0.000192	0.000194	CcSEcCtD
Cefuroxime—Nausea—Capecitabine—prostate cancer	0.000192	0.000193	CcSEcCtD
Cefuroxime—Dizziness—Prednisone—prostate cancer	0.00019	0.000191	CcSEcCtD
Cefuroxime—Musculoskeletal discomfort—Doxorubicin—prostate cancer	0.000189	0.000191	CcSEcCtD
Cefuroxime—Dyspnoea—Doxorubicin—prostate cancer	0.000185	0.000187	CcSEcCtD
Cefuroxime—Somnolence—Doxorubicin—prostate cancer	0.000185	0.000186	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Epirubicin—prostate cancer	0.000184	0.000185	CcSEcCtD
Cefuroxime—Dyspepsia—Doxorubicin—prostate cancer	0.000183	0.000184	CcSEcCtD
Cefuroxime—Vomiting—Prednisone—prostate cancer	0.000183	0.000184	CcSEcCtD
Cefuroxime—Rash—Prednisone—prostate cancer	0.000181	0.000183	CcSEcCtD
Cefuroxime—Dermatitis—Prednisone—prostate cancer	0.000181	0.000182	CcSEcCtD
Cefuroxime—Decreased appetite—Doxorubicin—prostate cancer	0.000181	0.000182	CcSEcCtD
Cefuroxime—Headache—Prednisone—prostate cancer	0.00018	0.000181	CcSEcCtD
Cefuroxime—Gastrointestinal disorder—Doxorubicin—prostate cancer	0.00018	0.000181	CcSEcCtD
Cefuroxime—Urticaria—Epirubicin—prostate cancer	0.000179	0.00018	CcSEcCtD
Cefuroxime—Pain—Doxorubicin—prostate cancer	0.000178	0.000179	CcSEcCtD
Cefuroxime—Abdominal pain—Epirubicin—prostate cancer	0.000178	0.000179	CcSEcCtD
Cefuroxime—Body temperature increased—Epirubicin—prostate cancer	0.000178	0.000179	CcSEcCtD
Cefuroxime—Nausea—Prednisone—prostate cancer	0.000171	0.000172	CcSEcCtD
Cefuroxime—Gastrointestinal pain—Doxorubicin—prostate cancer	0.00017	0.000171	CcSEcCtD
Cefuroxime—Hypersensitivity—Epirubicin—prostate cancer	0.000166	0.000167	CcSEcCtD
Cefuroxime—Urticaria—Doxorubicin—prostate cancer	0.000165	0.000166	CcSEcCtD
Cefuroxime—Body temperature increased—Doxorubicin—prostate cancer	0.000164	0.000166	CcSEcCtD
Cefuroxime—Abdominal pain—Doxorubicin—prostate cancer	0.000164	0.000166	CcSEcCtD
Cefuroxime—Pruritus—Epirubicin—prostate cancer	0.000159	0.00016	CcSEcCtD
Cefuroxime—Diarrhoea—Epirubicin—prostate cancer	0.000154	0.000155	CcSEcCtD
Cefuroxime—Hypersensitivity—Doxorubicin—prostate cancer	0.000153	0.000154	CcSEcCtD
Cefuroxime—Dizziness—Epirubicin—prostate cancer	0.000149	0.00015	CcSEcCtD
Cefuroxime—Pruritus—Doxorubicin—prostate cancer	0.000147	0.000148	CcSEcCtD
Cefuroxime—Vomiting—Epirubicin—prostate cancer	0.000143	0.000144	CcSEcCtD
Cefuroxime—Diarrhoea—Doxorubicin—prostate cancer	0.000142	0.000143	CcSEcCtD
Cefuroxime—Rash—Epirubicin—prostate cancer	0.000142	0.000143	CcSEcCtD
Cefuroxime—Dermatitis—Epirubicin—prostate cancer	0.000142	0.000143	CcSEcCtD
Cefuroxime—Headache—Epirubicin—prostate cancer	0.000141	0.000142	CcSEcCtD
Cefuroxime—Dizziness—Doxorubicin—prostate cancer	0.000138	0.000139	CcSEcCtD
Cefuroxime—Nausea—Epirubicin—prostate cancer	0.000134	0.000134	CcSEcCtD
Cefuroxime—Vomiting—Doxorubicin—prostate cancer	0.000132	0.000133	CcSEcCtD
Cefuroxime—Rash—Doxorubicin—prostate cancer	0.000131	0.000132	CcSEcCtD
Cefuroxime—Dermatitis—Doxorubicin—prostate cancer	0.000131	0.000132	CcSEcCtD
Cefuroxime—Headache—Doxorubicin—prostate cancer	0.00013	0.000131	CcSEcCtD
Cefuroxime—Nausea—Doxorubicin—prostate cancer	0.000124	0.000124	CcSEcCtD
